Christophe Meyer

PKIDB: A Curated, Annotated and Updated Database of Protein Kinase Inhibitors in Clinical Trials

Fabrice Carles, Stéphane Bourg, Christophe Meyer et al. · Molecules · 2018 · 182 citations · Full text

Drug Target, Kinase Inhibitors, Pharmacotherapy +26

Crystal Structures for HIV-1 Reverse Transcriptase in Complexes with Three Pyridinone Derivatives:  A New Class of Non-Nucleoside Inhibitors Effective against a Broad Range of Drug-Resistant Strains

D.M. Himmel, Kalyan Das, Arthur D. Clark et al. · Journal of Medicinal Chemistry · 2005 · 136 citations

Ring Opening in the Hydrostannation of Methylenecyclopropanes:  Effect of the Catalyst and Substrate

Mark Lautens, Christophe Meyer, Alexander Lorenz · Journal of the American Chemical Society · 1996 · 101 citations

Substratemark Lautens, Chemical Engineering, Novel Organocatalysts +12

Selection of a Respiratory Syncytial Virus Fusion Inhibitor Clinical Candidate. 2. Discovery of a Morpholinopropylaminobenzimidazole Derivative (TMC353121)

Jean‐François Bonfanti, Christophe Meyer, Frédéric Doublet et al. · Journal of Medicinal Chemistry · 2008 · 97 citations

Diarylquinolines, Synthesis Pathways and Quantitative Structure–Activity Relationship Studies Leading to the Discovery of TMC207

Jérôme Guillemont, Christophe Meyer, Alain Poncelet et al. · Future Medicinal Chemistry · 2011 · 94 citations

Pulmonary Tuberculosis, Drug Resistance Analysis, Natural Product Synthesis +14